JPWO2021041989A5 - - Google Patents
Download PDFInfo
- Publication number
- JPWO2021041989A5 JPWO2021041989A5 JP2022513477A JP2022513477A JPWO2021041989A5 JP WO2021041989 A5 JPWO2021041989 A5 JP WO2021041989A5 JP 2022513477 A JP2022513477 A JP 2022513477A JP 2022513477 A JP2022513477 A JP 2022513477A JP WO2021041989 A5 JPWO2021041989 A5 JP WO2021041989A5
- Authority
- JP
- Japan
- Prior art keywords
- pharmaceutical composition
- antibody
- days
- treating
- single dose
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP2025084157A JP2025124708A (ja) | 2019-08-29 | 2025-05-20 | Ａ型インフルエンザ感染の治療のための組成物及び方法 |
Applications Claiming Priority (7)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US201962893747P | 2019-08-29 | 2019-08-29 | |
| US62/893,747 | 2019-08-29 | ||
| US202062993519P | 2020-03-23 | 2020-03-23 | |
| US62/993,519 | 2020-03-23 | ||
| US202063040966P | 2020-06-18 | 2020-06-18 | |
| US63/040,966 | 2020-06-18 | ||
| PCT/US2020/048635 WO2021041989A1 (en) | 2019-08-29 | 2020-08-28 | Compositions and methods for treatment of influenza a infection |
Related Child Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2025084157A Division JP2025124708A (ja) | 2019-08-29 | 2025-05-20 | Ａ型インフルエンザ感染の治療のための組成物及び方法 |
Publications (3)
| Publication Number | Publication Date |
|---|---|
| JP2022545553A JP2022545553A (ja) | 2022-10-27 |
| JPWO2021041989A5 true JPWO2021041989A5 (https=) | 2023-09-04 |
| JP2022545553A5 JP2022545553A5 (https=) | 2023-09-04 |
Family
ID=72473986
Family Applications (2)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2022513477A Pending JP2022545553A (ja) | 2019-08-29 | 2020-08-28 | Ａ型インフルエンザ感染の治療のための組成物及び方法 |
| JP2025084157A Pending JP2025124708A (ja) | 2019-08-29 | 2025-05-20 | Ａ型インフルエンザ感染の治療のための組成物及び方法 |
Family Applications After (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2025084157A Pending JP2025124708A (ja) | 2019-08-29 | 2025-05-20 | Ａ型インフルエンザ感染の治療のための組成物及び方法 |
Country Status (11)
| Country | Link |
|---|---|
| US (1) | US20220306728A1 (https=) |
| EP (1) | EP4021502A1 (https=) |
| JP (2) | JP2022545553A (https=) |
| KR (1) | KR20220061999A (https=) |
| CN (1) | CN115052630A (https=) |
| AU (1) | AU2020335922A1 (https=) |
| BR (1) | BR112022003529A2 (https=) |
| CA (1) | CA3148990A1 (https=) |
| IL (1) | IL290752B2 (https=) |
| MX (1) | MX2022002447A (https=) |
| WO (1) | WO2021041989A1 (https=) |
Family Cites Families (15)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US5959177A (en) | 1989-10-27 | 1999-09-28 | The Scripps Research Institute | Transgenic plants expressing assembled secretory antibodies |
| WO1993006217A1 (en) | 1991-09-19 | 1993-04-01 | Genentech, Inc. | EXPRESSION IN E. COLI OF ANTIBODY FRAGMENTS HAVING AT LEAST A CYSTEINE PRESENT AS A FREE THIOL, USE FOR THE PRODUCTION OF BIFUNCTIONAL F(ab')2 ANTIBODIES |
| US5789199A (en) | 1994-11-03 | 1998-08-04 | Genentech, Inc. | Process for bacterial production of polypeptides |
| US5840523A (en) | 1995-03-01 | 1998-11-24 | Genetech, Inc. | Methods and compositions for secretion of heterologous polypeptides |
| US6040498A (en) | 1998-08-11 | 2000-03-21 | North Caroline State University | Genetically engineered duckweed |
| CN100427603C (zh) | 1999-10-04 | 2008-10-22 | 麦迪卡格公司 | 调控外源基因转录的方法 |
| US7125978B1 (en) | 1999-10-04 | 2006-10-24 | Medicago Inc. | Promoter for regulating expression of foreign genes |
| WO2004076677A2 (en) | 2003-02-26 | 2004-09-10 | Institute For Research In Biomedicine | Monoclonal antibody production by ebv transformation of b cells |
| RU2529951C2 (ru) * | 2007-12-26 | 2014-10-10 | Ксенкор, Инк. | ВАРИАНТЫ Fc С ИЗМЕНЕННЫМ СВЯЗЫВАНИЕМ C FcRn |
| BRPI0914092B1 (pt) | 2008-10-22 | 2021-08-31 | Institute For Research In Biomedicine | Método de produção de um anticorpo a partir de células plasmáticas, método de produção de um anticorpo monoclonal a partir de células plasmáticas e método de produção de um anticorpo ou de um fragmento de anticorpo |
| US20140294812A1 (en) * | 2013-03-15 | 2014-10-02 | Xencor, Inc. | Fc variants that improve fcrn binding and/or increase antibody half-life |
| US10894083B2 (en) * | 2015-01-28 | 2021-01-19 | Pfizer Inc. | Stable aqueous anti-vascular endothelial growth factor (VEGF) antibody formulation |
| WO2017123685A1 (en) * | 2016-01-13 | 2017-07-20 | Medimmune, Llc | Method of treating influenza a |
| WO2019222674A1 (en) * | 2018-05-18 | 2019-11-21 | Chan Zuckerberg Biohub, Inc. | Epitope restriction for antibody selection |
| WO2020221450A1 (en) * | 2019-04-30 | 2020-11-05 | Humabs Biomed Sa | Antibodies and methods for treatment of influenza a infection |
-
2020
- 2020-08-27 IL IL290752A patent/IL290752B2/en unknown
- 2020-08-28 KR KR1020227010317A patent/KR20220061999A/ko active Pending
- 2020-08-28 AU AU2020335922A patent/AU2020335922A1/en active Pending
- 2020-08-28 EP EP20771696.0A patent/EP4021502A1/en active Pending
- 2020-08-28 US US17/638,630 patent/US20220306728A1/en active Pending
- 2020-08-28 JP JP2022513477A patent/JP2022545553A/ja active Pending
- 2020-08-28 BR BR112022003529A patent/BR112022003529A2/pt unknown
- 2020-08-28 WO PCT/US2020/048635 patent/WO2021041989A1/en not_active Ceased
- 2020-08-28 MX MX2022002447A patent/MX2022002447A/es unknown
- 2020-08-28 CN CN202080076781.6A patent/CN115052630A/zh active Pending
- 2020-08-28 CA CA3148990A patent/CA3148990A1/en active Pending
-
2025
- 2025-05-20 JP JP2025084157A patent/JP2025124708A/ja active Pending
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP3280675B2 (ja) | 多価ｄｔｐポリオワクチン | |
| JP2023109938A (ja) | 抗体製剤 | |
| JP2505944B2 (ja) | （Ｓ）―α―フルオロメチル―ヒスチジン及びそのエステルを含有するぜん息治療用医薬組成物 | |
| ES2267591T3 (es) | Combinaciones farmaceuticas que comprenden un antagonista del receptor p2t y melagatran. | |
| JP2016512262A (ja) | 血管炎の処置におけるレボセチリジン及びモンテルカストの使用 | |
| US20250367248A1 (en) | Treatment of Warts | |
| JP2023523248A (ja) | 顆粒球マクロファージコロニー刺激因子に基づく感染治療 | |
| JPH10158169A (ja) | 塩化トロスピウムを含んだ医薬製剤、その調整方法および使用方法 | |
| KR102879944B1 (ko) | Hiv 예방용 인테그라제 억제제 | |
| US7132453B2 (en) | Method of using prostacyclin to treat respiratory syncytial virus infections | |
| JPWO2021041989A5 (https=) | ||
| CN119700949A (zh) | 一种重组呼吸道合胞病毒疫苗及其制备方法和应用 | |
| JP2003171266A (ja) | キシリトールを含有する解熱性調剤 | |
| FI3407899T3 (fi) | Immunoestolääkitys toistuvia bakteeri-infektioita varten | |
| CN102327599A (zh) | 用于治疗骨髓增生异常综合征的组合物和方法 | |
| RU2678981C2 (ru) | Композиция от бешенства, содержащая адъювант pika | |
| TW202120092A (zh) | 化合物用於預防或治療移植物抗宿主病的用途 | |
| CN102389564A (zh) | 用于治疗骨髓增生异常综合征的组合物和方法及用途 | |
| JP7417339B1 (ja) | アデノウイルス感染又はアデノウイルス感染に伴う疾患の治療 | |
| US20240299530A1 (en) | Method for producing blood plasma product useful in the treatment of viral infections characterized by an uncontrolled release of proinflammatory cytokines | |
| US20220362190A1 (en) | Viral inactivation spray and gargling formulation | |
| WO2005063253A1 (ja) | アレルギー症状治療用医薬組成物 | |
| RU2249465C1 (ru) | Способ лечения и профилактики иммунодефицитных состояний и заболеваний, связанных с бактериальной или вирусной агрессией | |
| RU2333766C2 (ru) | Способы введения далбаванцина для лечения бактериальных инфекций | |
| US20230310467A1 (en) | PHARMACEUTICAL COMBINATION THERAPY AND PREVENTION WITH APROTININ + REMDESIVIR OF SARS-CoV-2 AND/OR DISEASE ASSOCIATED WITH THIS INFECTION, INCLUDI COVID-19 |